EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Atlas‐based assessment of hypomyelination: Quantitative MRI in Pelizaeus‐Merzbacher disease

Caroline Köhler iD, Paul Kuntke iD, Prativa Sahoo, Hannes Wahl iD, Sean C L Deoni iD, Jutta Gärtner, Steffi Dreha-Kulaczewski, Hagen H Kitzler

Human Brain Mapping · 2024

DOI: 10.1002/hbm.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Brain Mapping, 2024. Verfasst von Caroline Köhler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diagnostic and Interventional Neuroradiology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dres…. Hauptthemen laut MEDLINE: Pelizaeus-Merzbacher Disease, Myelin Sheath, Diffusion Tensor Imaging, Atlases as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Leukodystrophie Association Deutschland e.V..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pelizaeus‐Merzbacher disease (PMD) is a rare childhood hypomyelinating leukodystrophy. Quantification of the pronounced myelin deficit and delineation of subtle myelination processes are of high clinical interest. Quantitative magnetic resonance imaging (qMRI) techniques can provide in vivo insights into myelination status, its spatial distribution, and dynamics during brain maturation. They may serve as potential biomarkers to assess the efficacy of myelin‐modulating therapies. However, registration techniques for image quantification and statistical comparison of affected pediatric brains, especially those of low or deviant image tissue contrast, with healthy controls are not yet established. This study aimed first to develop and compare postprocessing pipelines for atlas‐based quantification of qMRI data in pediatric patients with PMD and evaluate their registration accuracy. Second, to apply an optimized pipeline to investigate spatial myelin deficiency using myelin water imaging (MWI) data from patients with PMD and healthy controls. This retrospective single‐center study included five patients with PMD (mean age, 6 years ± 3.8) who underwent conventional brain MRI and diffusion tensor imaging (DTI), with MWI data available for a subset of patients. Three methods of registering PMD images to a pediatric template were investigated. These were based on (a) T1‐weighted (T1w) images, (b) fractional anisotropy (FA) maps, and (c) a combination of T1w, T2‐weighted, and FA images in a multimodal approach. Registration accuracy was determined by visual inspection and calculated using the structural similarity index method (SSIM). SSIM values for the registration approaches were compared using a t test. Myelin water fraction (MWF) was quantified from MWI data as an assessment of relative myelination. Mean MWF was obtained from two PMDs (mean age, 3.1 years ± 0.3) within four major white matter (WM) pathways of a pediatric atlas and compared to seven healthy controls (mean age, 3 years ± 0.2) using a Mann–Whitney U test. Our results show that visual registration accuracy estimation and computed SSIM were highest for FA‐based registration, followed by multimodal, and T1w‐based registration (SSIM FA = 0.67 ± 0.04 vs. SSIM multimodal = 0.60 ± 0.03 vs. SSIM T1 = 0.40 ± 0.14). Mean MWF of patients with PMD within the WM pathways was significantly lower than in healthy controls MWF PMD = 0.0267 ± 0.021 vs. MWF controls = 0.1299 ± 0.039. Specifically, MWF was measurable in brain structures known to be myelinated at birth (brainstem) or postnatally (projection fibers) but was scarcely detectable in other brain regions (commissural and association fibers). Taken together, our results indicate that registration accuracy was highest with an FA‐based registration pipeline, providing an alternative to conventional T1w‐based registration approaches in the case of hypomyelinating leukodystrophies missing normative intrinsic tissue contrasts. The applied atlas‐based analysis of MWF data revealed that the extent of spatial myelin deficiency in patients with PMD was most pronounced in commissural and association and to a lesser degree in brainstem and projection pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelizaeus-Merzbacher DiseaseMyelin SheathDiffusion Tensor ImagingAtlases as TopicHumansMaleChildFemaleChild, PreschoolRetrospective StudiesMagnetic Resonance ImagingBrainWhite Matter

Stichwörter der Autor:innen

Pelizaeus‐Merzbacher diseasehypomyelinating leukodystrophymagnetic resonance imagingmedical image registrationneuroimagingwhite matter disorder

Autor:innen und Institutionen

  • Institute of Diagnostic and Interventional Neuroradiology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Department of Pediatrics and Adolescent Medicine, University Medical Center Göttingen, Göttingen, Germany.
  • Advanced Baby Imaging Lab, School of Engineering, Brown University, Providence, Rhode Island, USA.
  • Maternal, Newborn, and Child Health Discovery and Tools, Bill and Melinda Gates Foundation, Seattle, Washington, USA.

ORCID-Profile: Caroline Köhler, Paul Kuntke, Hannes Wahl, Sean C L Deoni

Förderung

  • European Leukodystrophie Association Deutschland e.V.

Zitieren

APA

Köhler, C., Kuntke, P., Sahoo, P., Wahl, H., Deoni, S. C. L., Gärtner, J., Dreha-Kulaczewski, S., & Kitzler, H. H. (2024). Atlas‐based assessment of hypomyelination: Quantitative MRI in Pelizaeus‐Merzbacher disease. Human Brain Mapping. https://doi.org/10.1002/hbm.70014

Vancouver

Köhler C, Kuntke P, Sahoo P, Wahl H, Deoni SCL, Gärtner J, et al. Atlas‐based assessment of hypomyelination: Quantitative MRI in Pelizaeus‐Merzbacher disease. Human Brain Mapping. 2024. doi:10.1002/hbm.70014

BibTeX
@article{Khler2024,
  author = {Köhler, Caroline and Kuntke, Paul and Sahoo, Prativa and Wahl, Hannes and Deoni, Sean C L and Gärtner, Jutta and Dreha-Kulaczewski, Steffi and Kitzler, Hagen H},
  title = {Atlas‐based assessment of hypomyelination: Quantitative MRI in Pelizaeus‐Merzbacher disease},
  journal = {Human Brain Mapping},
  year = {2024},
  doi = {10.1002/hbm.70014}
}
Kostenlos starten →